Monday rally
For the second Monday in-a-row, positive efficacy data on a potential Covid vaccine sent stocks climbing.
Read MoreFor the second Monday in-a-row, positive efficacy data on a potential Covid vaccine sent stocks climbing.
Read MoreThe economic recovery investment theme that seemed impossible less than a month ago as we approached the election and possible Covid-19 2nd wave has now become consensus as news on…
Read MoreOur economic recovery theme has become consensus, which means it is still due to pause as highlighted on 11/11 last week.
Read MoreManufacturing in New York state expanded in November, but at the slowest pace since August.
Read MoreLast week, the major equity indices tacked on solid gains except for the Nasdaq Comp, which declined by 0.55%.
Read MoreThe market has seen further gains above Friday's close on news another Covid-19 Vaccine has a 94% efficacy rate.
Read More…Wasn’t so unlucky for stocks. The major indices opened higher, added to the gains in the afternoon, and closed just off the day's highest levels.
Read MoreThe University of Michigan released its Consumer Sentiment Survey this morning, and it showed a decline in the three components.
Read MoreI wanted to add a bit of perspective on our view given week's volatility...
Read MoreIn speaking to the Financial Times Global Boardroom event, the New York Fed President doesn’t sound like he is worried about the excessive liquidity turning into inflation anytime soon. His…
Read More